PDS Biotechnology Corporation is making significant strides in cancer therapy, particularly in HPV-driven head and neck cancers. The VERSATILE-003 Phase 3 trial, combining Versamune HPV
PDS Biotechnology Corporation is making significant strides in cancer therapy, particularly in HPV-driven head and neck cancers. The VERSATILE-003 Phase 3 trial, combining Versamune HPV